Skip to main content

Table 1 Patient characteristics

From: Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation

 

Total (n)

%

With FDG-avid LN metastasis

%

Metastasis rate †

Total patients

473

 

204

 

43

  - Male

361

76

163

80

45

  - Female

112

24

41

20

36

Age at diagnosis

     

  - 20–49

38

8

22

11

58

  - 50–59

103

22

44

22

43

  - 60–69

156

33

70

34

45

  - 70–79

125

26

50

25

40

  - 80+

51

11

18

9

35

  Median (range)

66 (28–95)

 

64 (28–88)

  

Race

     

  - White

413

87

178

87

43

  - Black

24

5

9

4

36

  - Asian

18

4

9

4

50

  - Other/Not specified

18

4

8

4

44

Tumor stage

     

  - T1

22

5

9

4

41

  - T2

59

12

18

9

31

  - T3

345

73

148

73

43

  - T4

19

4

12

6

63

  - n/a

28

6

17

8

61

Tumor differentiation

     

  - well-differentiated

7

1

3

1

43

  - moderately-differentiated

219

46

95

47

43

  - poorly-differentiated

205

43

94

46

46

  - not specified

43

9

12

6

29

Tumor histology

     

  - Adenocarcinoma

338

71

138

68

41

  - Squamous Cell

135

29

66

32

49

Tumor location

     

 Upper Thoracic

57

12

31

15

54

  Cervical

15

3

3

1

20

  - Adenocarcinoma

1

7

1

33

100

  - Squamous Cell

14

93

2

67

14

  Upper Mediastinal

42

9

28

14

67

  - Adenocarcinoma

4

10

2

7

50

  - Squamous Cell

38

90

26

93

68

 Lower Thoracic

417

88

173

85

41

  Lower Mediastinal

188

40

73

36

39

  - Adenocarcinoma

124

66

46

63

37

  - Squamous Cell

634

34

27

37

42

  Gastroesophageal

229

48

100

49

44

  - Adenocarcinoma

210

92

89

89

42

  - Squamous Cell

19

8

11

11

58

  1. †Metastasis rate is the percentage of total patients in a given category with FDG-avid LNM